Provides Potential for Broad Regenerative Medicine Therapeutic Platform LOS ANGELES, May 06, 2014 (GLOBE NEWSWIRE via COMTEX) — Capricor Therapeutics, Inc. CAPR +10.64% , a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced ...
Read More »